InvVax Revenue and Competitors
Estimated Revenue & Valuation
- InvVax's estimated annual revenue is currently $775k per year.
- InvVax's estimated revenue per employee is $155,000
Employee Data
- InvVax has 5 Employees.
- InvVax grew their employee count by -17% last year.
InvVax's People
Name | Title | Email/Phone |
---|---|---|
1 | Research Associate | Reveal Email/Phone |
InvVax Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is InvVax?
InvVax was incorporated in January 2013. Located in sunny Southern California, it maintains a strong affiliation with the UCLA, where its technology was originally developed. InvVax has access to a wide network of leading investigators in diverse disciplines, including molecular virology, immunology, pharmacology, and clinical infectious diseases. As a fledgling company, we are seeking highly talented applicants for scientific, industrial, and management roles who are interested in building a novel platform for vaccine development, and have a burning desire to make a far-ranging impact on the global human population.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 5 | 25% | $4.5M |
#2 | $0.5M | 5 | -71% | N/A |
#3 | $0.6M | 5 | -99% | N/A |
#4 | $0.3M | 5 | 0% | N/A |
#5 | $0.5M | 5 | -29% | N/A |